Close

Sierra Oncology Inc (SRRA) KOL Panel Highlights Momelotinib’s Efficacy - H.C. Wainwright

Go back to Sierra Oncology Inc (SRRA) KOL Panel Highlights Momelotinib’s Efficacy - H.C. Wainwright
(NASDAQ: SRRA) Delayed: 54.99 --0 (-0%)
Previous Close $54.99    52 Week High
Open $54.99    52 Week Low
Day High $54.99    P/E N/A 
Day Low $54.99    EPS
Volume 195,753